PAVmed Inc. - Common Stock, par value $0.001 per share (PAVM)

CUSIP: 70387R403

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
6,367,621
Total 13F shares
1,224,831
Share change
+13,287
Total reported value
$735,397
Price per share
$0.60
Number of holders
29
Value change
+$3,569
Number of buys
8
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP 70387R403?
CUSIP 70387R403 identifies PAVM - PAVmed Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of PAVM - PAVmed Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Ayrton Capital LLC
13D/G
9.9%
1,226,316
$858,421 $0 31 Dec 2024
FIRST MANHATTAN CO. LLC.
13F 13D/G
Company
4.3%
from 13D/G
714,100
$515,152 31 Mar 2025
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.5%
92,674
$66,869 31 Mar 2025
13F
VANGUARD GROUP INC
13F
Company
1.3%
81,494
$58,757 31 Mar 2025
13F
BlackRock, Inc.
13F
Company
1.1%
72,660
$52,417 31 Mar 2025
13F
CAPTRUST FINANCIAL ADVISORS
13F
Company
1%
65,047
$46,925 31 Mar 2025
13F
James L. Cox
3/4/5
Director
class O/S missing
65,000
$40,508 22 Feb 2024
Joan B. Harvey
3/4/5
Director
class O/S missing
65,000
$40,508 22 Feb 2024
LPL Financial LLC
13F
Company
0.87%
55,531
$40,060 31 Mar 2025
13F
XTX Topco Ltd
13F
Company
0.37%
23,427
$16,900 31 Mar 2025
13F
Obermeyer Wealth Partners
13F
Company
0.34%
21,500
$15,510 31 Mar 2025
13F
STATE STREET CORP
13F
Company
0.33%
20,854
$15,044 31 Mar 2025
13F
NORTHERN TRUST CORP
13F
Company
0.18%
11,706
$8,445 31 Mar 2025
13F
Virtu Financial LLC
13F
Company
0.17%
11,119
$8,000 31 Mar 2025
13F
JANE STREET GROUP, LLC
13F
Company
0.17%
10,686
$7,709 31 Mar 2025
13F
XML Financial, LLC
13F
Company
0.16%
10,067
$7,262 31 Mar 2025
13F
MORGAN STANLEY
13F
Company
0.08%
4,792
$3,457 31 Mar 2025
13F
Tower Research Capital LLC (TRC)
13F
Company
0.07%
4,503
$3,248 31 Mar 2025
13F
CWM, LLC
13F
Company
0.07%
4,672
$3,000 31 Mar 2025
13F
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO
13F
Company
0.04%
2,241
$1,617 31 Mar 2025
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.02%
1,444
$1,042 31 Mar 2025
13F
UBS Group AG
13F
Company
mixed-class rows
4,364
mixed-class rows
$855 31 Mar 2025
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
class O/S missing
149,408
$837 31 Mar 2025
13F
CIBC Private Wealth Group LLC
13F
Company
0.01%
836
$503 31 Mar 2025
13F
CITADEL ADVISORS LLC
13F
Company
class O/S missing
41,721
$234 31 Mar 2025
13F
Allworth Financial LP
13F
Company
0%
295
$223 31 Mar 2025
13F
JONES FINANCIAL COMPANIES LLLP
13F
Company
0%
246
$185 31 Mar 2025
13F
SBI Securities Co., Ltd.
13F
Company
0%
108
$78 31 Mar 2025
13F
Federation Des Caisses Desjardins du Quebec
13F
Individual
0%
95
$68 31 Mar 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
0%
93
$67 31 Mar 2025
13F
OSAIC HOLDINGS, INC.
13F
Company
0%
74
$52 31 Mar 2025
13F
Binnacle Investments Inc
13F
Company
0%
67
$48 31 Mar 2025
13F
JPMORGAN CHASE & CO
13F
Company
0%
19
$14 31 Mar 2025
13F
AdvisorNet Financial, Inc
13F
Company
0%
5
$4 31 Mar 2025
13F
Steward Partners Investment Advisory, LLC
13F
Company
0%
1
$1 31 Mar 2025
13F
Brian J. DeGuzman
3/4/5
Chief Medical Officer
class O/S missing
50,000
18 Feb 2022

Institutional Holders of PAVmed Inc. - Common Stock, par value $0.001 per share (PAVM) as of Q2 2025

As of 30 Jun 2025, PAVmed Inc. - Common Stock, par value $0.001 per share (PAVM) was held by 29 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,224,831 shares. The largest 10 holders included FIRST MANHATTAN CO. LLC., GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, BlackRock, Inc., CAPTRUST FINANCIAL ADVISORS, LPL Financial LLC, JANE STREET GROUP, LLC, Obermeyer Wealth Partners, STATE STREET CORP, and NORTHERN TRUST CORP. This page lists 29 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders
30
Q2 2025 holders
29
Holder diff
-1
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 Value $ Q2 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .